TGM2 and breast neoplasm: The decrease in TG2 expression in primary tumors may be achieved by epigenetic gene silencing, since the hypermethylation of CpG islands partly covers both the transcriptional and translational start sites of the TGM2 gene in cultured human breast tumor cells [76].